Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) 17,040,640 exchangeable shares (the "Exchangeable Shares") are exchangeable for 17,040,640 shares of BioSig Technology, Inc. (the "Issuer") common stock, par value $0.001 per share (the "Shares"). Currently, 5.01% of the Exchangeable Shares are exchangeable for Shares and the remainder are exchangeable upon stockholder approval which is expected to occur within 60 days. (2) Based on 140,396,715 Shares outstanding as of July 22, 2025, which includes 31,326,659 Shares outstanding and 109,070,079 Exchangeable Shares.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) 17,040,640 Exchangeable Shares are exchangeable for 17,040,640 Shares. Currently, 5.01% of the Exchangeable Shares are exchangeable for Shares and the remainder are exchangeable upon stockholder approval which is expected to occur within 60 days. (2) Based on 140,396,715 Shares outstanding as of July 22, 2025, which includes 31,326,659 Shares outstanding and 109,070,079 Exchangeable Shares.


SCHEDULE 13G



 
Avanico Limited
 
Signature:/s/ Frank Giustra
Name/Title:Frank Giustra, Authorized Person
Date:07/25/2025
 
Frank Giustra
 
Signature:/s/ Frank Giustra
Name/Title:Frank Giustra, Authorized Person
Date:07/25/2025